Moneycontrol PRO

you are here: HomeNewsEye on indiaVideos3-Point Analysis | Why does India have upper hand in global vaccine plan?

SHOW NAMES

X

coronavirus

3-Point Analysis | Why does India have upper hand in global vaccine plan?

Here is a 3-Point Analysis to find out how India’s vaccine manufacturing prowess places it in the fight against COVID-19.

first published: Jul 28, 2020 10:23 pm

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Live: Nifty snaps 4-day winning streak but rises 1% this week | Closing Bell
Live: Can Bihar poll outcome trigger Nifty to reclaim 26,000-mark? | Opening Bell
Live: Nifty holds above 25,900 but off nearly 100 pts from day's high | Closing Bell
Live: Will Nifty reclaim 26,000-mark amid record low inflation in Oct? | Opening Bell

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347